Phenylbutazone, oxyphenbutazone labeling revised.
D000380:Agranulocytosis / Q000139:chemically induced*; D000741:Anemia, Aplastic / Q000139:chemically induced*; D004348:Drug Labeling; D006801:Humans; D010113:Oxyphenbutazone / Q000009:adverse effects*; D010653:Phenylbutazone / Q000009:adverse effects*
D010653:Phenylbutazone; D010113:Oxyphenbutazone